Clinical Trial Update: Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update: evaluating low-dose semaglutide for weight loss in obese non-diabetic Pakistani adults; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• OZEMPIC (semaglutide)
• WEGOVY (Semaglutide)

Snippet

Sponsor: Asian Institute Of Medical Sciences | Conditions: Obesity, Weight Reduction | Phase 4 | Status: RECRUITING